Tipifarnib
KO-TIP-015
Phase 1 small_molecule terminated
Quick answer
Tipifarnib for NSCLC is a Phase 1 program (small_molecule) at Kura Oncology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Kura Oncology
- Indication
- NSCLC
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated